You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

CLINICAL TRIALS PROFILE FOR ZEMPLAR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Zemplar

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00048438 ↗	Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)	Completed	Abbott	Phase 3	2002-02-01	The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
NCT00048451 ↗	Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)	Completed	Abbott	Phase 3	2002-02-01	The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
NCT00048516 ↗	Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)	Completed	Abbott	Phase 3	2002-02-01	The objective of this study is to determine whether paricalcitol is safe and effective compared to placebo in reducing elevated serum PTH levels in patients with chronic kidney disease.
NCT00053378 ↗	A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects	Completed	Abbott	Phase 2	2002-01-01	A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Zemplar

Condition Name

Chart
Table

Condition Name for Zemplar
Intervention	Trials
Secondary Hyperparathyroidism	17
Chronic Kidney Disease	17
Hemodialysis	5
Renal Insufficiency, Chronic	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Zemplar
Intervention	Trials
Kidney Diseases	38
Renal Insufficiency, Chronic	36
Hyperparathyroidism	23
Hyperparathyroidism, Secondary	22
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Zemplar

Trials by Country

Map
Table

Trials by Country for Zemplar
Location	Trials
United States	212
Greece	8
Spain	8
Poland	7
Malaysia	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Zemplar
Location	Trials
California	14
Texas	13
Florida	13
New York	12
Illinois	11
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Zemplar

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Zemplar
Clinical Trial Phase	Trials
Phase 4	18
Phase 3	13
Phase 2/Phase 3	1
[disabled in preview]	13
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Zemplar
Clinical Trial Phase	Trials
Completed	48
Terminated	9
Active, not recruiting	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zemplar

Sponsor Name

Chart
Table

Sponsor Name for Zemplar
Sponsor	Trials
Abbott	36
National Cancer Institute (NCI)	5
AbbVie (prior sponsor, Abbott)	5
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Zemplar
Sponsor	Trials
Industry	54
Other	49
NIH	6
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.